Chinese expert consensus on immunotherapy for gynecological malignant tumors (2023 edition)

Chinese expert consensus on immunotherapy for gynecological malignant tumors (2023 edition)

Immunotherapy, as the fourth largest anti-tumor treatment method, has made breakthrough progress in the field of cancer treatment. Checkpoint inhibitors have been widely used in the treatment of various malignant tumors, and a lot of clinical evidence and experience have also been accumulated in the...

Full description

Bibliographic Details
Main Author:	Society of Onco-Endocrinology of Chinese Anti-Cancer Association
Format:	Article
Language:	English
Published:	Editorial Office of China Oncology 2023-10-01
Series:	Zhongguo aizheng zazhi
Subjects:	\|immunotherapy\|gynecological malignant tumors\|immune checkpoint inhibitors
Online Access:	http://www.china-oncology.com/fileup/1007-3639/PDF/1698723455992-12434734.pdf

Similar Items

Expert consensus on genetic counseling in gynecological oncology (2023 edition)
Published: (2023-11-01)

Chinese expert consensus on immunotherapy for advanced non-small cell lung cancer with oncogenic driver mutations (2023 edition)
by: The Society of Cancer Precision Medicine of Chinese Anti-Cancer Association; The Lung Cancer Expert Group of Chinese Medical Association Publishing House, et al.
Published: (2024-05-01)

Application of the da Vinci robot in gynecologic malignancies: A bibliometric analysis (2005 – 2023)
by: Wenxiang Wang, et al.
Published: (2023-11-01)

Modern approach to the management of genitourinary syndrome in women with gynecological malignancies
by: Kovacevic Nina, et al.
Published: (2023-07-01)

Expert consensus on precision detection of intrahepatic cholangiocarcinoma (2024 edition)
by: Pathology Group, Chinese Society of Liver Cancer of Chinese Anti-Cancer Association; Liver Pathology Group, Chinese Society of Pathology of Chinese Anti-Cancer Association; Tumor Pathology Committee of Shanghai Anti-Cancer Association, Shanghai 200032, China
Published: (2025-02-01)

BUB1B and gynecological malignant tumors
by: HOU Yiying, WEI Fang
Published: (2024-12-01)

The Influence of Gynecological Malignancies and Patient Characteristics on Fall Risk Perception
by: Jingjing Gong, et al.
Published: (2024-05-01)

Recent Advances in Gynecological Malignancies: Focus on ASCO 2023
by: Olga Bodriagova, et al.
Published: (2023-09-01)

Current Update on PET/MRI in Gynecological Malignancies—A Review of the Literature
by: Mayur Virarkar, et al.
Published: (2023-01-01)

Application of organoids in drug screening of gynecological malignant tumors
by: JIANG Yuanyuan, WEI Wenfei, WU Jingya, LI Huawen
Published: (2024-11-01)

Intraoperative Flow Cytometry for the Characterization of Gynecological Malignancies
by: Zoi Anastasiadi, et al.
Published: (2022-09-01)

Improving clinical trial enrollment in minority racial and ethnic patients with gynecologic malignancy
by: Olivia D. Lara, et al.
Published: (2024-10-01)

Editorial: The challenge of immunity evaluation and immunotherapy in gynecologic and urologic oncology
by: Ruirong Tan, et al.
Published: (2023-08-01)

Targeting WEE1 Kinase in Gynecological Malignancies
by: Zhang W, et al.
Published: (2024-06-01)

Ferroptosis: a novel strategy to overcome chemoresistance in gynecological malignancies
by: Jing Xu, et al.
Published: (2024-07-01)

Expert consensus on perioperative comprehensive treatment for high risk prostate cancer (2023 edition)
by: Society of Male Reproductive System Oncology, China Anti-Cancer Association
Published: (2023-12-01)

Application progress of oncolytic virus combined with immunotherapy in the treatment of malignant tumors
by: LIANG Yingyun, CHEN Jianhua
Published: (2024-07-01)

Editorial: New immunotherapy strategies and related therapeutic targets for gastrointestinal malignancies
by: Ganesan Ramamoorthi
Published: (2024-03-01)

Primary lymphoma of the female genital tract masquerading as gynecological malignancy
by: Suhua Shi, et al.
Published: (2024-04-01)

Independent organelle and organelle—organelle interactions: essential mechanisms for malignant gynecological cancer cell survival
by: Ying Shen, et al.
Published: (2024-04-01)

The causal effects of genetically determined immune cells on gynecologic malignancies: a Mendelian randomization study
by: Yan Li, et al.
Published: (2024-04-01)

Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)
by: Xiufeng Liu, et al.
Published: (2024-01-01)

The effect of food deserts on gynecologic cancer survival
by: Nicole Lugo Santiago, et al.
Published: (2024-08-01)

Chinese expert consensus on whole-process management of oxaliplatin-induced hypersensitivity reactions (2024 edition)
by: Cancer Assessment Society of China Anti-Cancer Association, Cancer Pain Society of Fujian Anti-Cancer Association
Published: (2024-08-01)

Clinicopathological Pattern of Gynecological Malignancies at Tertiary Care Teaching Hospital
by: Shakira Perveen, et al.
Published: (2022-08-01)

Chinese expert consensus on perioperative integrated rehabilitation for radical prostatectomy (2024 edition)
by: Committee of Integrated Rehabilitation for Urogenital Tumors, Chinese Anti-Cancer Association
Published: (2024-09-01)

Advances in nano-immunotherapy for hematological malignancies
by: Jian Xu, et al.
Published: (2024-05-01)

Metabolic dysregulation in obese women and the carcinogenesis of gynecological tumors: A review
by: Dragana Tomić Naglić, et al.
Published: (2024-05-01)

Descriptive characteristics of gynecological malignant neoplasms
by: A. V. Rumyantseva, et al.
Published: (2021-10-01)

Editorial: Novel immune markers and predictive models for immunotherapy and prognosis in breast and gynecological cancers
by: Fuhao Wang, et al.
Published: (2024-05-01)

Expert Consensus on Management of Common Gynecological Malignancies Combining General Practice and Specialist
by: Gynecological Oncology Group of the Oncology Department of Capital Medical University
Published: (2025-03-01)

Checkpoint inhibition in hematologic malignancies
by: Aaron Tsumura, et al.
Published: (2023-10-01)

Frailty in middle-aged and older adult postoperative patients with gynecological malignancies structural equation modeling
by: Shuo Man, et al.
Published: (2024-09-01)

Uncovering potential targets for antibody-drug conjugates in the treatment of gynecologic malignancies
by: Yuying Jiang, et al.
Published: (2025-02-01)

Pain nursing for gynecologic cancer patients
by: Wei Wu, et al.
Published: (2023-07-01)

Editorial: Immunotherapy for hematological malignancies in children
by: Yusi Zhou, et al.
Published: (2023-10-01)

Hormone replacement therapy in surgical menopause after gynecological malignancies
by: Dragana Tomić Naglić, et al.
Published: (2024-11-01)

Oncofertility and Fertility Preservation for Women with Gynecological Malignancies: Where Do We Stand Today?
by: Valentina Di Nisio, et al.
Published: (2024-08-01)

VISTA in hematological malignancies: a review of the literature
by: Yuanjia Duan, et al.
Published: (2024-12-01)

New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3
by: Ioannis-Alexios Koumprentziotis, et al.
Published: (2024-01-01)